Figure 3

HLJDT-M, but not HLJDT, reduces hippocampal Aβ-plaque pathology in 3XTg-AD mice. Immunohitochemical labelling of Aβ with 4G8 antibody in representative figures taken from the coronal sections in 3XTg-AD mice were orally administered with HLJDT-M or HLJDT at doses of 1 and 2 g/kg per day for 6 months.